Fast Five Quiz: Are You Prepared to Confront Metastatic Breast Cancer?

Winston W. Tan, MD


December 21, 2021

Despite many advances in treatment, the median OS of metastatic breast cancer is about 3 years, and only 20%-30% of women survive longer than 5 years. According to the MBC Decade Report, progress in terms of improved outcomes, quality of life, awareness, and information regarding advanced breast cancer has been slow. Some recent studies have shown improved OS, largely due to advances in human epidermal growth factor receptor 2 (HER2)–positive breast cancer. Of note, enhanced survival is seen in an environment with access to the best available care.

For additional information, refer to the National Comprehensive Cancer Network (NCCN) Breast Cancer Clinical Practice Guidelines and the 5th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC5).

Learn more about the optimal management of metastatic breast cancer.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.